PB

Pivotal bioVenture Partners China

Asia, Shanghai, China, Shanghai

Description

An Investment Firm based In China.

Investor Profile

Pivotal bioVenture Partners China has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 29% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Seed, Series A rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series B (43%)
  • Seed (29%)
  • Series A (29%)

Country Focus

  • China (71%)
  • United States (29%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Life Science
  • Medical
  • Biopharma
  • Medical Device
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pivotal bioVenture Partners China frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 1
CC
Africa, Rabat-Sale-Zemmour-Zaer, Morocco, Rabat
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Nan Fung Life Sciences
North America, California, United States, San Francisco
Co-Investments: 5
Ascendis Pharma
North America, California, United States, Palo Alto
Co-Investments: 1
Morningside Group
North America, Massachusetts, United States, Newton Center
Co-Investments: 2
Volcanics Venture
Asia, Shanghai, China, Changning
Co-Investments: 2
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Pivotal bioVenture Partners China often collaborate with?

Adrian Cheng
Asia, Hong Kong
Shared Deals: 1

What are some of recent deals done by Pivotal bioVenture Partners China?

Heranova Lifesciences

Huangpu, Shanghai, China

Hekaiwei is a provider of innovative solutions for women's health.

Health CareMedical
SeedDec 28, 2023
Amount Raised: $3,500,000
Ablaze Pharmaceuticals

Jingan, Shanghai, China

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.

BiotechnologyMedicalPharmaceutical
Series ANov 29, 2021
Amount Raised: $75,000,000
Arctic Vision

Shanghai, Shanghai, China

Arctic Vision is focused on the development and commercialization of innovative ophthalmology therapies.

BiotechnologyHealth CareLife Science
Series BMar 9, 2021
Amount Raised: $100,000,000
Visen Pharmaceuticals

Shanghai, Shanghai, China

Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.

BiotechnologyLife SciencePharmaceutical
Series BJan 8, 2021
Amount Raised: $150,000,000
Arctic Vision

Shanghai, Shanghai, China

Arctic Vision is focused on the development and commercialization of innovative ophthalmology therapies.

BiotechnologyHealth CareLife Science
Series AJul 13, 2020
Amount Raised: $32,000,000
OncXerna Therapeutics

Waltham, Massachusetts, United States

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

BiopharmaBiotechnologyHealth CareMedical DevicePharmaceuticalPrecision Medicine
Series BJun 10, 2019
Amount Raised: $80,000,000
OncXerna Therapeutics

Waltham, Massachusetts, United States

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

BiopharmaBiotechnologyHealth CareMedical DevicePharmaceuticalPrecision Medicine
SeedJun 7, 2018
Amount Raised: $16,500,000

Find More Investors Like Pivotal bioVenture Partners China

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Pivotal bioVenture Partners China | Pipeseed